Vaccine Market Growth, Size, Share Analysis, Trends, and Forecast 2025-2033
- Rahul Pal
- Mar 4
- 4 min read
According to the latest report by IMARC Group, titled “Vaccine Market Report by Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), and Region 2025-2033”, offers a comprehensive analysis of the industry, which comprises insights on the global vaccine market growth. The report also includes competitor and regional analysis, and contemporary advancements in the global market.
The global vaccine market size reached USD 59.8 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 136.5 Billion by 2033, exhibiting a growth rate (CAGR) of 9.12% during 2025-2033.
Global Vaccine Market Dynamics:
Rising Prevalence of Infectious Diseases and Pandemics:
An essential component of the global vaccine market is the vaccine's growth rate for emerging infectious diseases and its use during pandemics. The globalization of trade, increase in tourism, and climate changes are driving resurgence of infectious diseases which makes it necessary to develop vaccines. Gaps in the control of existing diseases and the rise of new unknown pathogens will always demand effective vaccines to solve them. This need gives rise to consistent market opportunities and technological advancements.
Growing Geriatric Population and Chronic Diseases:
Simultaneously, there is gradual increase in the world's population, which is a result of a steady improvement in health services and a growing elderly population along with chronic diseases associated with it. The elderly have weaker immunity which makes them highly prone to infections, thereby increasing the need for vaccines specifically for this population. The rise in chronic illnesses like cancer and heart disease further warrants the development of advanced vaccines that are able to target these diseases by altering the immune system. These shifts in growth patterns lend to flexibly high gaps in the vaccine market.
Technological Advancements and R&D Investments:
The market for vaccines is modernizing at a fast rate with new technologies owing to increased investment in research and development. New platforms for vaccine design like mRNA, viral vectors, and recombinant proteins are enabling more sophisticated and specific vaccines to be created. Additionally, progress in the field of immunology, genomics, and bioinformatics are speeding up the processes of vaccine discovery and development. The application of artificial intelligence and machine learning is further improving the designs of the vaccines through better optimization, enabling the realization of new era vaccines.
Request Free Sample Report: https://www.imarcgroup.com/vaccine-market/requestsample
Global Vaccine Market Trends:
Several new vaccine marketing approaches are being observed globally. A key approach that is being observed is the increased attention placed on the development and marketing of vaccine products and services focused on individualized and care cased vaccines. The development and marketing of vaccines that are based on individual genome and immune systems is a modernization in genomics and immunology that increases vaccine efficacy while decreasing negative side effects.
An additional important aspect is the new focus on vaccines used for issues other than infectious diseases. New vaccines for cancer, autoimmune, and neurodegenerative disease represent a developing frontier in vaccine disease prevention and treatment. Moreover, there is improving focus on and investment in providing affordable vaccines, especially in developing and middle income countries. Equitable vaccine supply places will have the greatest contribution to global health security.
By the IMARC Group, Some of the Top Competitive Landscape Operating in the Vaccine Market Report are Given Below:
Abbott Laboratories
Astellas Pharma Inc.
AstraZeneca Plc
Bharat Biotech International
Bavarian Nordic A/S
CSL Limited
Daiichi Sankyo Company Limited
Emergent BioSolutions Inc.
GlaxoSmithKline Plc
Inovio Pharmaceuticals Inc.
Johnson & Johnson
Merck & Co. Inc.
Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation)
Novavax Inc.
Panacea Biotec Ltd.
Pfizer Inc.
Sanofi Pasteur SA (Sanofi SA)
Serum Institute of India Pvt. Ltd.
Takeda Pharmaceutical Company Limited.
Explore the Full Report with Charts, Table of Contents, and List of Figures: https://www.imarcgroup.com/vaccine-market
Key Market Segmentation:
Breakup by Technology:
Conjugate Vaccines
Inactivated and Subunit Vaccines
Live Attenuated Vaccines
Recombinant Vaccines
Toxoid Vaccines
Others
Breakup by Patient Type:
Pediatric
Adult
Pediatric patients hold the largest share of the market
Breakup by Indication:
Bacterial Diseases
Meningococcal Disease
Pneumococcal Disease
Diphtheria/Tetanus/Pertussis (DPT)
Tuberculosis
Haemophilus Influenzae (Hib)
Typhoid
Others
Viral Diseases
Hepatitis
Influenza
Human Papillomavirus (HPV)
Measles/Mumps/Rubella (MMR)
Rotavirus
Herpes Zoster
Varicella
Japanese Encephalitis
Rubella
Polio
Rabies
Dengue
Others
Bacterial diseases presently account for the largest market share
Breakup by Route of Administration:
Intramuscular and Subcutaneous Administration
Oral Administration
Others
Intramuscular and subcutaneous administration represents the leading segment
Breakup by Product Type:
Multivalent Vaccine
Monovalent Vaccine
Multivalent vaccine represent the most used product type
Breakup by Treatment Type:
Preventive Vaccine
Therapeutic Vaccine
Preventive vaccine currently dominates the market
Breakup by End User:
Hospitals
Clinics
Vaccination Centers
Academic and Research Institutes
Others
Hospitals hold the largest share of the market
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Institutional Sales
Others
Hospital pharmacies presently account for the largest market share
Regional Insights:
North America (United States, Canada)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)
Asia Pacific exhibits a clear dominance in the market
Key highlights of the Report:
Market Performance
Market Outlook
COVID-19 Impact on the Market
Porter’s Five Forces Analysis
Historical, Current and Future Market Trends
Market Drivers and Success Factors
SWOT Analysis
Structure of the Market
Value Chain Analysis
Comprehensive Mapping of the Competitive Landscape
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
Comentários